Triple Antithrombotic Therapy vs Dual Antiplatelet for Prevention of Left Ventricular Thrombus After Anterior Myocardial Infarction: An Updated Meta-Analysis

Mustafa Abomohsen, Ibrahim Elkhayat, Ahmed Elmorsy Mohamed, Abdul Hakim Almakadma, Zeyad Kholeif, Ahmed Farid Gadelmawla, Ameer Awashra, Muhammed A. Youssef, Osamah AlQassab, Mohamed Ghannam, Vikas Patel, Azad Mojahedi, Iyad Idries, Meena Farid, Moshe Gunsburg, Hal L. Chadow, Department of Internal Medicine, Brookdale University Hospital , Medical Center, Department of Cardiology, El Zaitoun Specialized Hospital, Department of Internal Medicine, Baptist Hospital of Southeast Texas, Faculty of Medicine, Menoufia University, Department of Internal Medicine, An-Najah University, Department of Cardiology, th University, Division of Cardiology, One Brooklyn Health

Clinical and Applied Thrombosis/Hemostasis

Published online on July 10, 2026

Abstract

Clinical and Applied Thrombosis/Hemostasis, Volume 32, January-December 2026.
PurposeTo evaluate the efficacy and safety of triple antithrombotic therapy (TT) versus dual antiplatelet therapy (DAPT) for prevention of left ventricular thrombus (LVT) following anterior myocardial infarction.MethodsWe conducted a systematic review and ...